The role of the vascularized bone marrow component as a continuous source of donor-
derived hematopoietic stem cells that facilitate tolerance induction of vascularized composite …

Allograft rejection is one of the obstacles in achieving a successful vascularized composite
allotransplantation (VCA). Treatments of graft rejection with lifelong immunosuppression (IS) …

The field of vascularized composite allografts (VCAs) has undergone significant
advancement in recent decades, and VCAs are increasingly common and accepted in the …

Vascularized composite allotransplantation (VCA) is a field under research and has
emerged as an alternative option for the repair of severe disfiguring defects that result from …

Vascularized composite allotransplantation may now be considered a viable treatment
option in patients with complex craniofacial and limb defects. However, the field is still in its …

We herein summarize the progress made in VCA in the last year with a focus on new clinical
immunosuppressive strategies and novel targets for immunosuppression and …

The disrupted tissue in VCA and potential for repopulation by endothelial cells of the
recipient establish conditions that potentially decrease susceptibility to acute antibody …

Vascularized composite allotransplantation (VCA) has emerged as a treatment option for
treating nonlife-threatening conditions. Therefore, in order to make VCA a safe …

Advances in microsurgical techniques and immunosuppressive medication have rendered
transplantation of vascularized composite allografts possible, when autologous tissue is …

Since the start of the clinical vascularized composite allotransplantation (VCA) era over a
decade ago this field has witnessed significant developments in both basic and translational …